. Business Overview Recursion is a clinical-stage TechBio company with a mission to decode biology to radically improve lives. We have advanced a portfolio of differentiated internal programs and strategic partnerships powered by our integrated drug discovery and development platform, the Recursion Operating System (OS). This platform provides end-to-end, AI-native capabilities that span from novel biological ideas through the clinic, integrating multimodal biological data generation, AI-powered...
Q2 FY2026 — expected 2026-08-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001601830-26-000039 | EDGAR | 121K words |
| 2025-02-28 | 2024-12-31 | 0001601830-25-000035 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001601830-24-000019 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0001601830-23-000010 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0001601830-22-000012 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001601830-25-000166 | EDGAR | 23K words |
| 2025-08-05 | 2025-06-30 | 0001601830-25-000127 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0001601830-25-000075 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001601830-24-000196 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001601830-24-000115 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001601830-24-000052 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001601830-23-000069 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001601830-23-000057 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001601830-23-000023 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001601830-22-000035 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001601830-22-000030 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001601830-22-000024 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001601830-26-000054 | EDGAR | 1K words |
| 2026-02-25 | 0001601830-26-000038 | EDGAR | — |
| 2026-01-12 | 0001601830-26-000002 | EDGAR | — |
| 2025-12-08 | 0001601830-25-000174 | EDGAR | — |
| 2025-11-26 | 0001601830-25-000172 | EDGAR | — |
| 2025-11-05 | 0001601830-25-000164 | EDGAR | — |
| 2025-10-29 | 0001601830-25-000152 | EDGAR | — |
| 2025-08-05 | 0001601830-25-000126 | EDGAR | — |
| 2025-07-08 | 0001193125-25-156440 | EDGAR | — |
| 2025-06-18 | 0001601830-25-000088 | EDGAR | — |
116 total filings indexed. 89 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001601830 |
| Ticker | RXRX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.recursion.com |
| Listed | 2021-04-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report